Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Puretech Health PLC    PRTC   GB00BY2Z0H74

PURETECH HEALTH PLC (PRTC)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Sales11,84,431,893,301,371,00
EBITDA-42,9-72,4-113-130-147-169
Operating profit (EBIT)-43,6-73,9-115-131-151-172
Pre-Tax Profit (EBT)-56,3-83,2--123-130-136
Net income-39,4-48,930,9-68,3-64,1-67,3
P/E ratio-11,4-6,93--10,5-10,5-10,5
EPS ( $ )-0,21-0,21--0,20-0,20-0,20
Dividend per Share ( $ )------
Yield------
Reference price ( $ )2.4021.4552.0252.103252.103252.10325
Announcement Date04/07/2016
09:05am
04/06/2017
06:33am
04/16/2018
09:56am
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201520162017201820192020
Debt------
Finance31027518295,550,5-
Operating income (EBITDA)-42,9-72,4-113-130-147-169
Leverage
(Debt/EBITDA)
------
Capital Expenditure3,463,682,093,004,004,30
Book Value Per Share (BVPS)-0,76 $0,90 $20,3 $-28,3 $-
Cash Flow per Share-0,15 $---0,55 $--
Announcement Date04/07/2016
09:05am
04/06/2017
06:33am
04/16/2018
09:56am
---
Balance Sheet Analysis
Assessed data source :
© 2018 Thomson Reuters
Financial Ratios

Size 2018e 2019e
Capitalization 591 M$ -
Entreprise Value (EV) 495 M$ 540 M$
Valuation 2018e 2019e
P/E ratio (Price / EPS)
Capitalization / Revenue 179x 432x
EV / Revenue 150x 395x
EV / EBITDA -3,80x -3,68x
Yield (DPS / Price) - -
Price to book (Price / BVPS) 0,10x -0,07x
Profitability 2018e 2019e
Operating Margin (EBIT / Sales) -3 961% -11 041%
operating Leverage (Delta EBIT / Delta Sales) - -0,26x
Net Margin (Net Profit / Revenue) -2 070% -4 690%
ROA (Net Profit / Asset) - -
ROE (Net Profit / Equities) - -
Rate of Dividend - -
Balance Sheet Analysis 2018e 2019e
CAPEX / CA   90,9% 293%
Cash Flow / Sales -4 707% -
Capital Intensity (Assets / Sales) - -
Financial Leverage (Net Debt / EBITDA) 0,73x 0,34x
EPS & Dividend